Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,035,082
-
Share change
-
+9,817,541
-
Total reported value
-
$16,822,135
-
Put/Call ratio
-
15%
-
Price per share
-
$0.56
-
Number of holders
-
51
-
Value change
-
+$5,007,578
-
Number of buys
-
20
-
Number of sells
-
21
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q4 2021
As of 31 Dec 2021,
ACELRX PHARMACEUTICALS INC - COM (ACRX) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,035,082 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Rock Springs Capital Management LP, VANGUARD GROUP INC, D. E. Shaw & Co., Inc., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Values First Advisors, Inc., STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.